Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Allan

Showing results (271-280 of 315) with videos related to

Pageof 32
Sort By:
Blood|January 29, 2021
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse modelsTiziana Vaisitti, Francesca Arruga, Nicoletta Vitale, et al.
American Journal of Hematology|August 23, 2021
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.
The European Respiratory Journal|September 12, 2017
Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to <i>Haemophilus influenzae</i> biofilm formationWoolf T Walker, Claire L Jackson, Raymond N Allan, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
Cellular and Molecular Life Sciences : CMLS|April 9, 2025
Complementary approaches define the metabolic features that accompany Richter syndrome transformationGiulia Omezzolli, Andrea Iannello, Francesco E Vallone, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic ToleranceRaymond N Allan, Samantha Morgan, Sanjita Brito-Mutunayagam, et al.
American Journal of Hematology|February 12, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.
NPJ Biofilms and Microbiomes|October 31, 2020
An integrated model system to gain mechanistic insights into biofilm-associated antimicrobial resistance in Pseudomonas aeruginosa MPAO1Adithi R Varadarajan, Raymond N Allan, Jules D P Valentin, et al.
Cancer|April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.
Journal of Global Antimicrobial Resistance|February 19, 2017
Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infectionMatthew S Dryden, Jonathan Cooke, Rami J Salib, et al.
Pageof 32

Showing results (271-280 of 315) with videos related to

Sort By:
Pageof 32
Blood|January 29, 2021
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse modelsTiziana Vaisitti, Francesca Arruga, Nicoletta Vitale, et al.
American Journal of Hematology|August 23, 2021
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.
The European Respiratory Journal|September 12, 2017
Primary ciliary dyskinesia ciliated airway cells show increased susceptibility to <i>Haemophilus influenzae</i> biofilm formationWoolf T Walker, Claire L Jackson, Raymond N Allan, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
Cellular and Molecular Life Sciences : CMLS|April 9, 2025
Complementary approaches define the metabolic features that accompany Richter syndrome transformationGiulia Omezzolli, Andrea Iannello, Francesco E Vallone, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic ToleranceRaymond N Allan, Samantha Morgan, Sanjita Brito-Mutunayagam, et al.
American Journal of Hematology|February 12, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.
NPJ Biofilms and Microbiomes|October 31, 2020
An integrated model system to gain mechanistic insights into biofilm-associated antimicrobial resistance in Pseudomonas aeruginosa MPAO1Adithi R Varadarajan, Raymond N Allan, Jules D P Valentin, et al.
Cancer|April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.
Journal of Global Antimicrobial Resistance|February 19, 2017
Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infectionMatthew S Dryden, Jonathan Cooke, Rami J Salib, et al.
Pageof 32